Related Experiment Video
Updated: Feb 13, 2026

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
Published on: July 11, 2025
Activity loss by H46A mutation in Mycobacterium tuberculosis isocitrate lyase is due to decrease in structural
Rohit Shukla1, Harish Shukla1, Timir Tripathi1
1Molecular and Structural Biophysics Laboratory, Department of Biochemistry, North-Eastern Hill University, Shillong 793022, India.
A mutation in Mycobacterium tuberculosis isocitrate lyase (MtbICL), an anti-tuberculosis drug target, inactivates the enzyme. Computational analysis revealed this H46A mutation disrupts the active site, leading to loss of MtbICL function.
Area of Science:
- Biochemistry
- Structural Biology
- Computational Biology
Background:
- Mycobacterium tuberculosis isocitrate lyase (MtbICL) is essential for glyoxylate cycle function and a validated target for anti-tuberculosis drug development.
- A specific mutation, H46A, located away from the active site, has been observed to abolish MtbICL enzyme activity.
Purpose of the Study:
- To investigate the structural and dynamic mechanisms by which the H46A mutation leads to the loss of MtbICL enzyme activity.
- To elucidate the allosteric effects of the H46A mutation on MtbICL structure and dynamics.
Main Methods:
- Molecular docking
- Molecular dynamics (MD) simulations
- Residue Interaction Network (RIN) analysis
- Principal Component Analysis (PCA)
- Cross-correlation analysis
Main Results:
- MD simulations and PCA revealed altered conformational flexibility and collective motion modes in the H46A mutant compared to wild-type MtbICL, particularly around the active site.
- RIN analysis indicated a disturbed active site geometry in the mutant enzyme.
- The H46A mutation induced dynamic perturbations that shifted the enzyme from an active to an inactive conformation.
Conclusions:
- The H46A mutation causes significant allosteric changes, leading to active site disruption and enzyme inactivation.
- Understanding these mutation-induced dynamics and interactions is crucial for designing novel anti-tuberculosis drugs and improving existing therapies.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Local Anesthetics: Chemistry and Structure-Activity Relationship
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Co-activators and Co-repressors

